BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
POT
Potash Corp Of Saskatchewan
POT
|
+$716M |
| 2 |
Apple
AAPL
|
+$677M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$561M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$554M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$497M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$3.85B |
| 2 |
Equinix
EQIX
|
+$2.31B |
| 3 |
Tesla
TSLA
|
+$2.3B |
| 4 |
SNDK
SANDISK CORP
SNDK
|
+$1.87B |
| 5 |
TRLA
TRULIA INC (DEL)
TRLA
|
+$1.64B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.8% |
| 2 | Financials | 3.08% |
| 3 | Industrials | 1.77% |
| 4 | Healthcare | 1.71% |
| 5 | Materials | 1.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Alnylam Pharmaceuticals
ALNY
$30.5B
| $135K | ﹤0.01% |
2,134
+1,134
| +113% | +$67.4K |
|
|
TWO
1852
Two Harbors Investment
TWO
$1.26B
| $135K | ﹤0.01% |
1,605
-2,579
| -62% | -$214K |
|
1853
ProShares Ultra FTSE China 50 of PROSHARES TRUST
XPP
$8.29M
| $134K | ﹤0.01% |
2,449
+2,349
| +2,349% | +$120K |
|
|
FNFG
1854
DELISTED
FIRST NIAGARA FINANCIAL GROUP INC
FNFG
| $133K | ﹤0.01% |
15,273
-58,404
| -79% | -$517K |
|
1855
CoreCivic
CXW
$3.18B
| $133K | ﹤0.01% |
4,052
-17,663
| -81% | -$576K |
|
|
MFA
1856
MFA Financial
MFA
$925M
| $133K | ﹤0.01% |
4,038
-4,360
| -52% | -$141K |
|
1857
Columbia Sportswear
COLM
$2.93B
| $132K | ﹤0.01% |
3,202
+722
| +29% | +$30.1K |
|
|
LHO
1858
DELISTED
LaSalle Hotel Properties
LHO
| $132K | ﹤0.01% |
+3,746
| New | +$124K |
|
1859
Granite Construction
GVA
$5.57B
| $132K | ﹤0.01% |
3,659
-1,179
| -24% | -$43.1K |
|
1860
Dick's Sporting Goods
DKS
$18.2B
| $132K | ﹤0.01% |
2,826
-9,962
| -78% | -$487K |
|
1861
CALL
Lumen
LUMN
$6.66B
| $131K | ﹤0.01% |
1,653
+1,006
| +155% | +$36.1K |
|
1862
CALL
Southern Copper
SCCO
$157B
| $131K | ﹤0.01% |
2,637
+2,419
| +1,110% | +$65.8K |
|
|
MDVN
1863
DELISTED
MEDIVATION, INC.
MDVN
| $131K | ﹤0.01% |
3,400
-3,078
| -48% | -$104K |
|
|
PCYC
1864
DELISTED
PHARMACYCLICS INC
PCYC
| $131K | ﹤0.01% |
1,460
-2,658
| -65% | -$249K |
|
1865
White Mountains Insurance
WTM
$5.08B
| $131K | ﹤0.01% |
215
-519
| -71% | -$309K |
|
1866
Zillow
ZG
$7.95B
| $130K | ﹤0.01% |
2,739
-1,842
| -40% | -$67.6K |
|
|
1867
PUT
Southern Copper
SCCO
$157B
| $130K | ﹤0.01% |
2,637
+2,419
| +1,110% | +$65.8K |
|
|
IPXL
1868
DELISTED
Impax Laboratories, Inc.
IPXL
| $130K | ﹤0.01% |
4,337
+1,123
| +35% | +$30.3K |
|
|
EOD
1869
Allspring Global Dividend Opportunity Fund
EOD
$289M
| $130K | ﹤0.01% |
15,313
-25,687
| -63% | -$210K |
|
1870
CALL
Eli Lilly
LLY
$1.05T
| $129K | ﹤0.01% |
1,000
| – | – |
|
1871
Douglas Emmett
DEI
$1.96B
| $129K | ﹤0.01% |
4,558
-12,014
| -72% | -$334K |
|
|
WRI
1872
DELISTED
Weingarten Realty Investors
WRI
| $129K | ﹤0.01% |
3,915
-18,068
| -82% | -$568K |
|
1873
Ulta Beauty
ULTA
$22B
| $128K | ﹤0.01% |
1,402
-2,641
| -65% | -$238K |
|
|
GXP
1874
DELISTED
Great Plains Energy Incorporated
GXP
| $128K | ﹤0.01% |
4,767
-9,310
| -66% | -$243K |
|
1875
Calix
CALX
$2.5B
| $127K | ﹤0.01% |
15,519
+15,019
| +3,004% | +$123K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2014 Portfolio in Review
As of Q2 2014, BNP Paribas Financial Markets held 4,108 positions worth $106B, down 17% from $129B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
BNP Paribas Financial Markets deployed $44.2B of net new capital in Q2 2014, opening 765 new positions and adding to 1,315 existing holdings. Its largest new stake was Canadian Pacific Kansas City: 15,162,685 shares worth $560M.
By sector, the portfolio is most concentrated in Technology at 4.8% of assets, down from 26% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Gilead Sciences, an estimated $3.85B trimmed.
- BNP Paribas Financial Markets's largest Q2 2014 buy was Canadian Pacific Kansas City: 15,162,685 shares worth $560M.
- BNP Paribas Financial Markets added most to Potash Corp Of Saskatchewan in Q2 2014, an estimated $716M increase.
- BNP Paribas Financial Markets's biggest Q2 2014 reduction was Gilead Sciences, cutting an estimated $3.85B.
- BNP Paribas Financial Markets fully exited Walter Investment Mgt Corp in Q2 2014, selling an estimated $477M.
- BNP Paribas Financial Markets's ten largest holdings make up 42% of its $106B portfolio in Q2 2014.
- BNP Paribas Financial Markets opened 765 new positions and closed 285 in Q2 2014.
- BNP Paribas Financial Markets's portfolio value fell 17% quarter-over-quarter to $106B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2014, filed 14 Aug 2014.